Market Place
Sourcing Support
All News #Library
Biotech
Seres Therapeutics To Present At CARB-X Investor Day
09 Apr 2026 //
GLOBENEWSWIRE
Seres Focuses On Emerging Inflammatory & Immune Disease Programs
12 Feb 2026 //
GLOBENEWSWIRE
Seres Unveils Vowst`s Mechanism in Top Journals
06 Jan 2026 //
GLOBENEWSWIRE
Seres Therapeutics Unveils Q3 2025 Financials & Business
05 Nov 2025 //
GLOBENEWSWIRE
Seres Gets Up To $3.6M From CARB-X For SER-155 Formulation
29 Oct 2025 //
GLOBENEWSWIRE
Seres Reduces Head Count by 25% to Fund Biotherapeutic`s Ph 2
23 Sep 2025 //
FIERCE BIOTECH
Seres Therapeutics Reports Q2 2025 Financials and Updates
06 Aug 2025 //
GLOBENEWSWIRE
Seres Therapeutics to Announce Q2 2025 Results and Updates
22 Jul 2025 //
GLOBENEWSWIRE
Seres Therapeutics Reports Q1 2025 Results and Business Updates
07 May 2025 //
GLOBENEWSWIRE
FDA Grants Breakthrough Designation to Seres for HSCT Infections
09 Dec 2024 //
GLOBENEWSWIRE
Seres to Participate in Piper Sandler Healthcare Conference
22 Nov 2024 //
GLOBENEWSWIRE
CDSCO panel gives nod for continuation of ph-II trial of SII`s dengue vaccine
06 Jun 2024 //
ECONOMICTIMES
Seres’ Investigational SER-109 ECOSPOR IV Data Published in JAMA NETWORK OPEN
14 Feb 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.